|
Aaseth, J., P. Dusek, and P. M. Roos. 2018. "Prevention of progression in Parkinson's disease." Biometals. Ackert-Bicknell, C. L., L. C. Anderson, S. Sheehan, W. G. Hill, B. Chang, G. A. Churchill, E. J. Chesler, R. Korstanje, and L. L. Peters. 2015. "Aging Research Using Mouse Models." Curr Protoc Mouse Biol 5(2):95-133. Aguilera, M., M. Cerda-Cuellar, and V. Martinez. 2015. "Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice." Gut Microbes 6(1):10-23. B. K. Harvey, Y. Wang, and B. J. Hoffer. 2008. "Transgenic rodent models of Parkinson’s disease." Acta Neurochir Suppl 101:89-92. Capato, T. T., J. Tornai, P. Avila, E. R. Barbosa, and M. E. Piemonte. 2015. "Randomized controlled trial protocol: balance training with rhythmical cues to improve and maintain balance control in Parkinson's disease." BMC Neurol 15:162. Caputi, V., and M. C. Giron. 2018. "Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease." Int J Mol Sci 19(6). Chen, R. C., S. F. Chang, C. L. Su, T. H. Chen, M. F. Yen, H. M. Wu, Z. Y. Chen, and H. H. Liou. 2001. "Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan." Neurology 57(9):1679-86. de Lau, L. M., and M. M. Breteler. 2006. "Epidemiology of Parkinson's disease." Lancet Neurol 5(6):525-35. Didari, T., S. Mozaffari, S. Nikfar, and M. Abdollahi. 2015. "Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis." World J Gastroenterol 21(10):3072-84. Fernandez, H. H. 2015. "2015 Update on Parkinson disease." Cleve Clin J Med 82(9):563-8. Galland, L. 2014. "The gut microbiome and the brain." J Med Food 17(12):1261-72. Galter, Mats I. Ekstrand and Dagmar. 2009. "The MitoPark Mouse – An animal model of Parkinson’s disease with impaired respiratory chain function in dopamine neurons." Parkinsonism and Related Disorders 15(3):185-88. Gareau, M. G., E. Wine, D. M. Rodrigues, J. H. Cho, M. T. Whary, D. J. Philpott, G. Macqueen, and P. M. Sherman. 2011. "Bacterial infection causes stress-induced memory dysfunction in mice." Gut 60(3):307-17. Kadastik-Eerme, L., M. Rosenthal, T. Paju, M. Muldmaa, and P. Taba. 2015. "Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms." Health Qual Life Outcomes 13:83. Kalia, Lorraine V., and Anthony E. Lang. 2015. "Parkinson's disease." The Lancet 386(9996):896-912. Lee, D. J., R. F. Dallapiazza, P. De Vloo, and A. M. Lozano. 2018. "Current surgical treatments for Parkinson's disease and potential therapeutic targets." Neural Regen Res 13(8):1342-45. Lee, H. M., and S. B. Koh. 2015. "Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease." J Mov Disord 8(2):92-7. Li, X., L. Redus, C. Chen, P. A. Martinez, R. Strong, S. Li, and J. C. O'Connor. 2013. "Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease." PLoS One 8(8):e71341. Luong, T. N., H. J. Carlisle, A. Southwell, and P. H. Patterson. 2011. "Assessment of motor balance and coordination in mice using the balance beam." J Vis Exp (49). Mats I. Ekstrand, Mu¨ gen Terzioglu†, Dagmar Galter, Shunwei Zhu, Christoph Hofstetter, Eva Lindqvist,, Anita Bergstrand Sebastian Thams, Fredrik Sterky Hansson, Aleksandra Trifunovic, Barry Hoffer,, and Abdul H. Mohammed Staffan Cullheim, Lars Olson, and Nils-Go¨ran Larsson. 2007. "Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons." Proc Natl Acad Sci US A. 104(4):1325-30. McDonald, W. M., I. H. Richard, and M. R. DeLong. 2003. "Prevalence, etiology, and treatment of depression in Parkinson's disease." Biol Psychiatry 54(3):363-75. Meng, X. H., P. Liu, H. Wang, X. F. Zhao, Z. M. Xu, G. H. Chen, and D. X. Xu. 2011. "Gender-specific impairments on cognitive and behavioral development in mice exposed to fenvalerate during puberty." Toxicol Lett 203(3):245-51. Miller, B. H., L. E. Schultz, A. Gulati, A. I. Su, and M. T. Pletcher. 2010. "Phenotypic characterization of a genetically diverse panel of mice for behavioral despair and anxiety." PLoS One 5(12):e14458. Mulak, A., and B. Bonaz. 2015. "Brain-gut-microbiota axis in Parkinson's disease." World J Gastroenterol 21(37):10609-20. Obeso, J. A., M. C. Rodriguez-Oroz, P. Chana, G. Lera, M. Rodriguez, and C. W. Olanow. 2000. "The evolution and origin of motor complications in Parkinson's disease." Neurology 55(11 Suppl 4):S13-20; discussion S21-3. Ostadhadi, S., A. Haj-Mirzaian, V. Nikoui, N. Kordjazy, and A. R. Dehpour. 2016a. "Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice." Clin Exp Pharmacol Physiol 43(2):203-12. Ostadhadi, S., M. Imran Khan, A. Norouzi-Javidan, and A. R. Dehpour. 2016b. "Antidepressant effect of pramipexole in mice forced swimming test: A cross talk between dopamine receptor and NMDA/nitric oxide/cGMP pathway." Biomed Pharmacother 81:295-304. Parashar, A., and M. Udayabanu. 2017. "Gut microbiota: Implications in Parkinson's disease." Parkinsonism Relat Disord 38:1-7. Perez-Pardo, P., T. Kliest, H. B. Dodiya, L. M. Broersen, J. Garssen, A. Keshavarzian, and A. D. Kraneveld. 2017. "The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies." Eur J Pharmacol 817:86-95. Pusceddu, M. M., K. Murray, and M. G. Gareau. 2018. "Targeting the Microbiota, from Irritable Bowel Syndrome to Mood Disorders: Focus on Probiotics and Prebiotics." Curr Pathobiol Rep 6(1):1-13. Rial, D., A. A. Castro, N. Machado, P. Garcao, F. Q. Goncalves, H. B. Silva, A. R. Tome, A. Kofalvi, O. Corti, R. Raisman-Vozari, R. A. Cunha, and R. D. Prediger. 2014. "Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease." PLoS One 9(12):e114216. Rogers, M. W. 1996. "Disorders of posture, balance, and gait in Parkinson's disease." Clin Geriatr Med 12(4):825-45. Savignac, H. M., M. Tramullas, B. Kiely, T. G. Dinan, and J. F. Cryan. 2015. "Bifidobacteria modulate cognitive processes in an anxious mouse strain." Behav Brain Res 287:59-72. Seibenhener, M. L., and M. C. Wooten. 2015. "Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice." J Vis Exp (96):e52434. Taylor, A. M., and H. D. Holscher. 2018. "A review of dietary and microbial connections to depression, anxiety, and stress." Nutr Neurosci:1-14. Taylor, T. N., J. G. Greene, and G. W. Miller. 2010. "Behavioral phenotyping of mouse models of Parkinson's disease." Behav Brain Res 211(1):1-10. Valente, A. X., R. P. das Neves, and P. J. Oliveira. 2012. "Epigenetic engineering to reverse the Parkinson's expression state." Parkinsonism Relat Disord 18(6):717-21. Xu, N., W. Fan, X. Zhou, Y. Liu, P. Ma, S. Qi, and B. Gu. 2018. "Probiotics decrease depressive behaviors induced by constipation via activating the AKT signaling pathway." Metab Brain Dis. Yang, Mia Kim Ki-Ho Cho Mal-Soon Shin Jae-Min Lee Han-Sam Cho Chang-Ju Kim Dong-Hoon Shin Hyeon Jeong. 2014. "Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease." International Journal of Molecular Medicine:870-78.
|